Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Alzheimer's Disease Risk Alleles Profiled in Latino Populations

By LabMedica International staff writers
Posted on 24 Dec 2018
The apolipoprotein E (APOE) gene encodes three common isoforms known as ε2, ε3, and ε4. More...
These are determined by two single nucleotide polymorphisms (SNPs) that result in amino acid substitutions and associated functional changes in the protein.

The APOε4 isoform is associated with increased circulating levels of total cholesterol and low-density lipoprotein (LDL), cardiovascular risk, Alzheimer’s disease (AD), and related dementias (ADRD); whereas APOε2 is associated with cognitive resilience and extended longevity.

A team of scientists collaborating with the University of Texas Health Science Center (Houston, TX, USA) used a custom array to genotype APOE in nearly 10,900 individuals with diverse Latino ancestry from four metropolitan areas in the USA. The genotyped participants included representatives from Central American, Cuban, Dominican, Mexican, Puerto Rican, and South American populations, and had an average age of just over 41 years and slightly more than half of the target population (50.4%) was female. Genome-wide SNP genotyping was performed on the participants using a custom Illumina array consisting of the HumanOmni2.5–8v1–1 array content along with a panel of ∼150,000 investigator-chosen SNPs.

The team found that Dominican, Puerto Rican, and Cuban individuals tended to have higher frequencies of the well known ADRD and cognitive decline risk allele APOε4. That risky APOε4 allele was found at almost 18% frequency in Dominicans, while Cubans and Puerto Ricans carried the allele at intermediate frequency. However, it appeared to be far less common in individual from mainland populations in Mexico, Central America, and South America, which had APOε4 frequencies of around 11%.

Conversely, the team found that the APOε2 allele, which has been proposed as a protective factor against cognitive decline and ADRD, was found at enhanced frequencies in individuals from Caribbean Latino populations, dipping in individuals from Central America, and turning up at the lowest frequencies in the South American and Mexican populations. The APOε3 allele, the most common version of APOE across human populations profiled so far, was found in more than 86% of Mexicans and in almost 74% of Dominicans.

The authors concluded that the APOE allele and genotype frequency distributions in a large and diverse sample of Latinos with well-characterized ancestry background. These data provide valuable information in this understudied ethnic group and provide the basis for future studies of the association of APOE with ADRD in this fast-growing segment of the US population. The study was published on December 13, 2018, in the journal Scientific Reports.

Related Links:
University of Texas Health Science Center


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple daily blood test could help critically ill sepsis patients stop antibiotics sooner, reducing overuse and potentially helping combat antibiotic resistance (Image Credit: Adobe Stock)

Daily Blood Biomarker Testing May Help Guide Earlier Antibiotic Stopping in Sepsis

Sepsis is a life-threatening condition caused by the body’s overwhelming response to infection and accounts for thousands of deaths each year. In intensive care, concern about stopping treatment too early... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.